Advanced Flower Capital Inc.
Advanced Flower Capital Inc. Q1 FY2025 earnings call
May 14, 2025 · fiscal period ended 2025-03
EPS · actual vs est
Revenue · actual vs est
Summary
Generated 2025-05-14
Management highlights
- Robyn Tannenbaum discussed the cannabis industry, noting ongoing capital market uncertainty due to federal reform lack, growing supply-demand imbalance in capital, and an active pipeline of $287 million as of May 1, 2025, focusing on backing successful operators with prior track records.
- Daniel Neville provided an overview of first quarter performance, highlighted a recent $14 million senior secured credit facility to Standard Wellness Holdings, discussed liquidation process for private company A (Georgia assets sold for $15 million), progress with private company A-K (receiver has LOIs for asset sales), and legal proceedings with Justice Grown (pre-discovery preliminary injunction received).
- Brandon Hetzel summarized financial results, mentioned net interest income, distributable earnings, portfolio details, renewal of senior secured credit facility to $100 million with prime plus 50 basis points interest rate, and financial metrics like total assets, shareholder equity, and book value per share.
Segment performance
For the first quarter of 2025, AFC generated distributable earnings of $0.21 per basic weighted average share of common stock. Net interest income was $6.6 million. As of March 31, 2025, principal outstanding was $366.3 million across 17 loans, with a weighted average portfolio yield to maturity of approximately 18%. Total assets were $321.7 million, total shareholder equity $200.8 million, and book value per share $8.89. As of May 1, 2025, active pipeline had $287 million of deals, and portfolio principal outstanding was $372.5 million across 18 loans.
Guidance
- Management will be opportunistic in originations due to cannabis market volatility and federal uncertainty, focusing on high-quality borrowers and proven operators.
- Board of Directors to make dividend declaration on normal cadence around June 15, with dividend policy at 85% to 100% over an entire year.
Risks
- Uncertainty in cannabis industry due to lack of federal reform, potentially leading to muted originations if investments don't meet criteria.
- Underperformance of legacy loans impacting earnings.
- Legal proceedings with Justice Grown, including a preliminary injunction barring exercise of certain rights, creating uncertainty in protecting shareholders' capital.
Q&A highlights
Q: Looking at the interest income number, what caused the decline and non-recurring fees?
A: Decline due to less income from subsidiary of private company G ($1.6 million in Q4 2024 vs $600,000 in Q1 2025) and no TRS dividends in Q1; offset by new originations.
Q: Progression of net book growth and distributable earnings?
A: Originations will be opportunistic based on high-quality borrowers; dividend declaration on June 15 by Board.
Q: Inflows from proceeds of company A's Georgia asset?
A: Uncertain as AFC is a participant in the loan, timing out of control, can't give guidance on amount.
Q: Opportunity in Pennsylvania state-run framework for private lenders?
A: Pennsylvania Senate rejected state-run model proposal, not likely outcome for adult-use legalization, not an opportunity for AFC.
Q: Pipeline growth expectations and yields?
A: Originations will be opportunistic due to market volatility; yields consistent with recent history while moving up quality curve with proven operators.
Key numbers
Reported versus consensus
Earnings calendar feed
| Metric | Reported | Consensus | Delta | Prior year |
|---|---|---|---|---|
| EPS | — | — | — | — |
| Revenue | — | — | — | — |
Transcript
May 14, 2025Full transcript unavailable for redistribution
The structured summary above covers the available call sections. Full transcript text is not included on this page.
Continue exploring
Prior quarters
This page presents the stored structured earnings-call summary and deterministic earnings calendar values. How this is generated. For informational purposes only; not investment advice.